12/16/2014 - 10:28am

Actavis on Tuesday announced the planned senior management team that will lead the global pharmaceutical company following the successful close of the acquisition of Allergan.

12/16/2014 - 10:14am

Dr. Reddy's Labs announced the launch of valganciclovir tablets USP in 450-mg strength. 

 

12/11/2014 - 2:24pm

Teva Pharmaceuticals on Thursday announced the availability of levalbuterol inhalation solution, USP (concentrate), a generic equivalent to Xopenex inhalation solution concentrate. 

12/11/2014 - 2:15pm

Lupin Pharmaceuticals launched the authorized generic version of Celebrex capsules in 50-, 100-, 200- and 400-mg dosage strengths. 

12/11/2014 - 12:21pm

Mylan on Thursday announced the launch of methocarbamol injection USP, 100 mg. 

12/11/2014 - 12:14pm

Mylan on Thursday announced the launch of prednisolone sodium phosphate orally disintegrating tablets in 10-mg, 15-mg and 30-mg dosage strengths. 

 

12/10/2014 - 9:51am

Teva Pharmaceutical Industries on Wednesday announced the launch of generic Celebrex (celecoxib) capsules in the United States. The company is offering the capsules in 50-,100-, 200- and 400-mg dosage strengths. 

 

12/10/2014 - 9:39am

Mylan on Wednesday launched its celecoxib capsules in 50-, 100-, 200- and 400-mg dosage strengths. The drug is one of the first available generic versions of Celebrex capsules from Pfizer.

12/09/2014 - 4:09pm

Reps. Doug Collins, R-Ga., and Dave Loebsack, D-Iowa, introduced on Tuesday H.R. 5815 — the Generic Drug Pricing Fairness Act — which creates greater transparency in how PBMs reimburse pharmacies for generic prescription drugs under Medicare Part D, the military’s TRICARE program, and the Federal Employees Health Benefits Program.